Clinical Trial Update: Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and Bevacizumab [Phase 2]

View source ↗

Summary

A Phase 2 trial assessing irinotecan plus cediranib for metastatic colorectal cancer after prior oxaliplatin, fluoropyrimidine, and bevacizumab failed or was te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Camptosar (irinotecan)
• Cediranib (Cediranib)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Colorectal Cancer | Phase 2 | Status: TERMINATED | Results posted: 2017-03-03